Ingelheim am Rhein, Germany

Rainer Sobotta



 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 102(Granted Patents)


Location History:

  • Ingelheim, DE (1996 - 2009)
  • Ingelheim am Rhein, DE (1983 - 2013)

Company Filing History:


Years Active: 1983-2013

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovations of Rainer Sobotta: A Pioneer in Benzimidazole Derivatives

Introduction: Rainer Sobotta, an accomplished inventor based in Ingelheim am Rhein, Germany, has made significant contributions to the field of pharmaceuticals through his innovative work on benzimidazole derivatives. With a remarkable portfolio of 17 patents, Sobotta continues to push the boundaries of medical science.

Latest Patents: Among Sobotta's most notable inventions is a patented process for preparing a benzimidazole derivative, which serves as a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate. His efforts in this area exemplify his dedication to advancing drug development and improving patient outcomes.

Career Highlights: Sobotta’s extensive career includes working with prominent companies such as Boehringer Ingelheim KG and Boehringer Ingelheim International GmbH. His expertise and innovative mindset have been instrumental in developing new pharmaceutical compounds that are crucial in modern medicine.

Collaborations: Throughout his career, Rainer Sobotta has collaborated with esteemed colleagues such as Herbert Merz and Rudolf Bauer. These partnerships have undoubtedly enriched his work and fostered a culture of innovation within their teams.

Conclusion: Rainer Sobotta stands out as a notable inventor in the pharmaceutical industry, with a track record of impactful innovations. His commitment to developing new compounds and processes not only demonstrates his expertise but also his dedication to enhancing medical therapies for a better future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…